SONM
insider transactionsDNA X, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Michael C Mulica KEY
Acting CEO
$0
50.0K sh
Own +1228%
-
Grant·A
Clayton Crolius KEY
Chief Financial Officer
$0
35.0K sh
Own +2036%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Feb 9, 2026 | Michael C Mulica KEY | Grant A | 50.0K | $0 |
| Feb 9, 2026 | Clayton Crolius KEY | Grant A | 35.0K | $0 |
About SONM insider trading
This page tracks insider transactions for DNA X, Inc. (SONM) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.